NEW YORK STOCK EXCHANGE, INC. · BAX
+0.23% · +$0.0500 · Vol 45.9K
Live · updated 09:31:02 ET
Baxter International Inc

Baxter International Inc

Health Care
$23.70
Card
Relationship Map

Follow $BAX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $BAX by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
BAX
Baxter International Inc
Thu Oct 1 · last completed session · daily score · 16h old
Highest qualified

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

79/ 100
Veridion Score
Highest qualified · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 1 · last completed session · daily score · 16h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is BAX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading BAX catalysts
About Baxter International Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
1961
Employees
38K
Country
US

Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$23.84
Day high
$23.84
Day low
$23.69
Previous close
$23.64
52W high
$28.35
-16.42% from high
52W low
$15.80
63% of range
Market cap
$12.2B
P/E
40.85×
EPS
$0.5800
Beta
0.55
Shares out
517M
Volume
45.9K
0.01× rel vol
Avg volume
6.1M
VWAP
$23.73
Price history computed in-house
1W
+1.39%
1M
-7.80%
3M
+4.61%
1Y
+2.00%
YTD
+23.99%
SMA 50 $25.22 · below
SMA 200 $20.81 · above
52W position 63%

BAX overview

Loading financial statements
Loading BAX Form 4 filings
Public disclosures

Congress activity in BAX

Federal contracts

BAX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for BAX in this window.
Lobbying spend

BAX lobbying filings, year to date.

Registered lobbying filings matched to Baxter International Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for BAX in this window.
Loading news for BAX
Analyst ratings
Sovereign unlock shows live analyst consensus for BAX.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.